持田製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4534/E00947 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2013/04/19 | 日証協 | 490,524株 | +5.6% | 199,000株 | -1% | 497,559株 | -0.99% | 96,786株 | +136.06% |
2013/04/12 | 日証協 | 464,524株 | -4.52% | 201,000株 | -46.83% | 502,559株 | -8.39% | 41,000株 | -51.19% |
2013/04/05 | 日証協 | 486,524株 | +21.41% | 378,000株 | +87.13% | 548,559株 | +20.24% | 84,000株 | +36.96% |
2013/03/29 | 日証協 | 400,724株 | +33.7% | 202,000株 | -46.46% | 456,228株 | +18.64% | 61,331株 | -78.56% |
2013/03/22 | 日証協 | 299,724株 | -12.03% | 377,282株 | +113.15% | 384,559株 | +4.58% | 286,009株 | +157.45% |
2013/03/15 | 日証協 | 340,724株 | -17.64% | 177,000株 | -49.03% | 367,726株 | -20.43% | 111,091株 | +184.85% |
2013/03/08 | 日証協 | 413,724株 | -20.85% | 347,273株 | +49.73% | 462,167株 | -14.12% | 39,000株 | -0.06% |
2013/03/01 | 日証協 | 522,724株 | -3.57% | 231,926株 | +40.96% | 538,167株 | -8.71% | 39,024株 | +25.88% |
2013/02/22 | 日証協 | 542,098株 | +2.26% | 164,531株 | +44.33% | 589,537株 | +0.34% | 31,000株 | +138.46% |
2013/02/15 | 日証協 | 530,098株 | +2.14% | 114,000株 | -7.57% | 587,537株 | -1.18% | 13,000株 | -67.06% |
2013/02/08 | 日証協 | 518,998株 | +1.96% | 123,333株 | -21.31% | 594,537株 | +0.51% | 39,465株 | -70.52% |
2013/02/01 | 日証協 | 508,998株 | +0.99% | 156,730株 | +16.99% | 591,537株 | +2.07% | 133,860株 | +81.22% |
2013/01/25 | 日証協 | 503,998株 | -3.06% | 133,965株 | -24.31% | 579,537株 | -3.68% | 73,865株 | +71.78% |
2013/01/18 | 日証協 | 519,933株 | +10.17% | 177,000株 | +60.91% | 601,672株 | +5.06% | 43,000株 | -56.17% |
2013/01/11 | 日証協 | 471,933株 | -2.66% | 110,000株 | +423.81% | 572,672株 | -1.53% | 98,101株 | 0% |
2013/01/04 | 日証協 | 484,833株 | +0.21% | 21,000株 | -88.84% | 581,571株 | 0% | 0株 | -100% |
2012/12/28 | 日証協 | 483,833株 | +9.26% | 188,100株 | -31.77% | 581,571株 | +5.8% | 42,000株 | -66.61% |
2012/12/21 | 日証協 | 442,833株 | +2.79% | 275,700株 | +20.83% | 549,672株 | 0% | 125,800株 | +39.21% |
2012/12/14 | 日証協 | 430,833株 | +13.13% | 228,165株 | -34.96% | 549,672株 | +7.64% | 90,365株 | +197.59% |
※株式分割は考慮していませんのでご注意ください。
Page Top